Skip to content
In English |
En español
National Cancer Institute
at the National Institutes of Health
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
Email This Document
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
LiveHelp online chat
Popular Resources
Help Using the NCI Clinical Trials Search Form
Learn About Clinical Trials
About NCI's List of Cancer Clinical Trials
NCI Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-25 of 55 for your search:
Drug:
methanol extraction residue of BCG
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase III Adjuvant Chemotherapy with DTIC vs Chemoimmunotherapy with DTIC/MER in Stage III/IV Malignant Melanoma
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
UMCC-7411
2.
Phase III Surgery and/or Chemotherapy with DRB and/or Immunotherapy with MER and Mononuclear Cell Transfusions for Hairy Cell Leukemia
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
MDA-DT-8010
3.
Phase III Individualized Chemotherapy of Adult Acute Leukemia Based on Predicted Outcome to Remission Induction and Maintenance Treatment
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
over 18
Sponsor:
Protocol IDs:
MDA-DT-7995
, NCI-D81-043-066
4.
Phase III Chemotherapy with CTX/MTX/VCR/5-FU/PRED with or without BCG Immunotherapy for Breast Carcinoma
Phase:
Phase III
Type:
Treatment
Status:
Completed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
CLB-7481
5.
Phase III Chemotherapy with ARA-C/DMN, ARA-C/TG/DMN, ARA-C/TG, or ARA-C/VCR/DM & MER-BCG Immunotherapy for Acute Myelocytic Leukemia
Phase:
Phase III
Type:
Treatment
Status:
Completed
Age:
any age
Sponsor:
NCI
Protocol IDs:
CLB-7521
, CALGB-7521
6.
Phase III Chemotherapy with VCR/CTX/ADR, Radiotherapy and MER-BCG Immunotherapy for Neuroblastoma, Stages III and IV
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
1 to 18
Sponsor:
NCI
Protocol IDs:
CLB-7541
7.
Adjuvant Chemotherapy with CTX/MTX/5-FU, CTX/MTX/5-FU/VCR/PRED and MER-BCG Immunotherapy after Mastectomy for Breast Carcinoma
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
under 75
Sponsor:
NCI
Protocol IDs:
CLB-7581
8.
Phase III VCR/L-ASP/PRED & DNM Induction, 6-MP/MTX/VCR/PRED Maintenance & MER-BCG for Acute Lymphocytic Leukemia
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
20 and over
Sponsor:
NCI
Protocol IDs:
CLB-7612
9.
Phase III Chemotherapy with DNM/HU/6-MP/CTX/PRED and Immunotherapy with MER-BCG for Resistant Chronic Granulocytic Leukemia
Phase:
Phase III
Type:
Treatment
Status:
Completed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
CLB-7631
10.
Phase III Chemotherapy with ADR or CTX/VCR/DTIC with or without MER-BCG Immunotherapy for Soft Tissue Sarcomas
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
CLB-7681
11.
Phase III Chemotherapy with CTX/MTX/5-FU, CTX/5-FU/ADR, CTX/5-FU/ADR/VCR/PRED & MER-BCG Immunotherapy for Breast Carconoma
Phase:
Phase III
Type:
Treatment
Status:
Completed
Age:
postmenopausal under 70
Sponsor:
NCI
Protocol IDs:
CLB-7682
, CALGB-7682
12.
Phase III MTX, ADR, CCNU, CTX, VCR Chemotherapy in Two Combinations plus Radiotherapy and MER Immunotherapy for Oat Cell Carcinoma of the Lung
Phase:
Phase III
Type:
Treatment
Status:
Completed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
CLB-7781
, CALGB-7781
13.
Phase III Adjuvant Immunotherapy with MER-BCG for High-Risk Stage I/II Malignant Melanoma of the Head, Neck, Extremities, and Trunk
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
YALE-HIC-1351
, NCI-T83-1147D
14.
Phase II Chemotherapy with Vindesine with or without MER-BCG for Metastatic Colorectal Cancer
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
MDA-DT-7737
15.
Phase II Therapy with MER-BCG plus Lithium Carbonate and Mononuclear Cell Transfusion for Oligoleukemia and Preleukemia
Phase:
Phase II
Type:
Supportive care
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
MDA-DT-7908
16.
Phase II Chemotherapy with BVDD (BLEO/VBL/DTIC/CACP) with vs without Intravenous MER-BCG for Stage IV Metastatic Melanoma
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
MDA-DT-8124
17.
Phase II Combination Chemotherapy with DAVA/DTIC plus MER Immunotherapy for Stage IV Metastatic Malignant Melanoma
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
over 15
Sponsor:
Protocol IDs:
MDA-DT-7996R
18.
Phase II Immunotherapy with BCG or MER-BCG for Cutaneous Metastases of Cancer
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
MSKCC-7010
19.
Phase II Combination Chemotherapy of 5-FU with MeCCNU, VCR, CACP, plus MER-BCG Immunotherapy for Advanced Colorectal Carcinoma
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
no age specified
Sponsor:
Protocol IDs:
MAYO-701833
20.
Phase II Chemotherapy with ADR/DTIC/ACT-D/CTX plus Adjuvant Immunotherapy with MER-BCG for Advanced Sarcoma
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
no age specified
Sponsor:
Protocol IDs:
MAYO-741202
21.
Phase II Radiotherapy plus VCR/ADR Chemotherapy with or without MER-BCG Immunotherapy for Squamous Cell Lung Cancer
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
no age specified
Sponsor:
Protocol IDs:
MAYO-752201/03
22.
ROAP - Rubidazone/VCR/ARA-C/PRED plus MER-BCG Immunotherapy for Acute Nonlymphocytic Leukemia
Phase:
No phase specified
Type:
Treatment
Status:
Closed
Age:
over 50
Sponsor:
Protocol IDs:
MDA-DT-7635A
23.
Chemotherapy with ROAP (RBD/VCR/ARA-C/PRED) plus Immunotherapy with MER for Acute Myelogenous Leukemia in Patients Over Age 50
Phase:
No phase specified
Type:
Supportive care, Treatment
Status:
Closed
Age:
over 50
Sponsor:
Protocol IDs:
MDA-DT-7760
24.
Combination Chemotherapy with ROAP (RBD/ARA-C/VCR/PRED), POMP (6-MP/VCR/MTX/PRED) and OAP (ARA-C/VCR/PRED) plus TG with or without MER for AML
Phase:
No phase specified
Type:
Treatment
Status:
Closed
Age:
under 60
Sponsor:
Protocol IDs:
MDA-DT-7926
25.
Bone Marrow Restoration with Lithium Carbonate and MER-BCG for Oligoleukemia and Pre-Leukemia
Phase:
No phase specified
Type:
Supportive care
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
MDA-DT-8035P
Select All on Page
1
Help with Results
We Can Answer Your Questions
1-800-4-CANCER
LiveHelp Online Chat
NCI Home
Contact Us
Policies
Accessibility
Viewing Files
FOIA
Site Help
Site Map
Other Versions of this Site:
Mobile
|
Español
Follow Us:
Twitter
YouTube
Facebook
RSS
NIH…Turning Discovery Into Health
®
Mobile | Español
Mobile | Español
